The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes
Clinical trial NCT01836523 · COMPLETED
Trial details
- NCT number
- NCT01836523
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2015-06-01
- Enrollment
- 1398
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.